Cargando…

PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism

BACKGROUND: Malignant melanoma is the most lethal form of skin cancer which shows BRAF mutation in 50% of patients. In this context, the identification of BRAF(V600E) mutation led to the development of specific inhibitors like PLX4032. Nevertheless, although its initial success, its clinical efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garbarino, Ombretta, Valenti, Giulia Elda, Monteleone, Lorenzo, Pietra, Gabriella, Mingari, Maria Cristina, Benzi, Andrea, Bruzzone, Santina, Ravera, Silvia, Leardi, Riccardo, Farinini, Emanuele, Vernazza, Stefania, Grottoli, Melania, Marengo, Barbara, Domenicotti, Cinzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391174/ https://www.ncbi.nlm.nih.gov/pubmed/37534247 http://dx.doi.org/10.3389/fonc.2023.1210130

Ejemplares similares

PKCα Inhibition as a Strategy to Sensitize Neuroblastoma Stem Cells to Etoposide by Stimulating Ferroptosis
por: Monteleone, Lorenzo, et al.
Publicado: (2021)

Vitamin C sensitizes BRAF(V600E) thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032
por: Su, Xi, et al.
Publicado: (2021)

Antiproliferative Imidazo-Pyrazole-Based Hydrogel: A Promising Approach for the Development of New Treatments for PLX-Resistant Melanoma
por: Alfei, Silvana, et al.
Publicado: (2023)

Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors
por: Choi, Jaehyuk, et al.
Publicado: (2014)

MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance
por: Marengo, Barbara, et al.
Publicado: (2019)

Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2021)

Association between acquired resistance to PLX4032 (vemurafenib) and ATP-binding cassette transporter expression
por: Michaelis, Martin, et al.
Publicado: (2014)

PLX4032 Mediated Melanoma Associated Antigen Potentiation in Patient Derived Primary Melanoma Cells
por: George, Andrea L., et al.
Publicado: (2015)

Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
por: Niehr, Franziska, et al.
Publicado: (2011)

The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells
por: Jenkins, Molly H., et al.
Publicado: (2015)

HO-1 Limits the Efficacy of Vemurafenib/PLX4032 in BRAF(V600E) Mutated Melanoma Cells Adapted to Physiological Normoxia or Hypoxia
por: Furfaro, Anna Lisa, et al.
Publicado: (2022)

Differential sensitivity of melanoma cell lines with BRAF(V600E )mutation to the specific Raf inhibitor PLX4032
por: Søndergaard, Jonas N, et al.
Publicado: (2010)

Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy
por: Bustos, Silvina Odete, et al.
Publicado: (2018)

Synthesis of Polystyrene-Based Cationic Nanomaterials with Pro-Oxidant Cytotoxic Activity on Etoposide-Resistant Neuroblastoma Cells
por: Alfei, Silvana, et al.
Publicado: (2021)

Adaptive up-regulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells
por: Basile, Kevin J., et al.
Publicado: (2011)

Induced cross-resistance of BRAF(V600E) melanoma cells to standard chemotherapeutic dacarbazine after chronic PLX4032 treatment
por: Erdmann, Sarah, et al.
Publicado: (2019)

Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2020)

Correction: Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2023)

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
por: Rubinstein, Jill C, et al.
Publicado: (2010)

Tyrphostin AG1296, a platelet-derived growth factor receptor inhibitor, induces apoptosis, and reduces viability and migration of PLX4032-resistant melanoma cells
por: Li, Yanling, et al.
Publicado: (2015)

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF(WT) melanoma cells
por: Halaban, Ruth, et al.
Publicado: (2010)

Imidazo-Pyrazole-Loaded Palmitic Acid and Polystyrene-Based Nanoparticles: Synthesis, Characterization and Antiproliferative Activity on Chemo-Resistant Human Neuroblastoma Cells
por: Valenti, Giulia Elda, et al.
Publicado: (2023)

Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells
por: Monteleone, Lorenzo, et al.
Publicado: (2022)

Colorectal cancer and therapy response: a focus on the main mechanisms involved
por: Tirendi, Sara, et al.
Publicado: (2023)

Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
por: Zhang, Honglai, et al.
Publicado: (2018)

Paradox Role of Oxidative Stress in Cancer: State of the Art
por: Domenicotti, Cinzia, et al.
Publicado: (2022)

Antimicrobial Peptides and Cationic Nanoparticles: A Broad-Spectrum Weapon to Fight Multi-Drug Resistance Not Only in Bacteria
por: Valenti, Giulia E., et al.
Publicado: (2022)

Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy
por: Marengo, Barbara, et al.
Publicado: (2016)

D-α-Tocopherol-Based Micelles for Successful Encapsulation of Retinoic Acid
por: Zuccari, Guendalina, et al.
Publicado: (2021)

Polyester-Based Dendrimer Nanoparticles Combined with Etoposide Have an Improved Cytotoxic and Pro-Oxidant Effect on Human Neuroblastoma Cells
por: Alfei, Silvana, et al.
Publicado: (2020)

Citicoline Eye Drops Protect Trabecular Meshwork Cells from Oxidative Stress Injury in a 3D In Vitro Glaucoma Model
por: Vernazza, Stefania, et al.
Publicado: (2022)

Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma
por: Colla, Renata, et al.
Publicado: (2016)

Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
por: Marengo, Barbara, et al.
Publicado: (2018)

Berberine Inhibits Human Melanoma A375.S2 Cell Migration and Invasion via Affecting the FAK, uPA, and NF-κB Signaling Pathways and Inhibits PLX4032 Resistant A375.S2 Cell Migration In Vitro
por: Liu, Jia-Fang, et al.
Publicado: (2018)

A Preliminary Color Study of Different Basil-Based Semi-Finished Products during Their Storage
por: Turrini, Federica, et al.
Publicado: (2022)

miRNA Regulation of Glutathione Homeostasis in Cancer Initiation, Progression and Therapy Resistance
por: Marengo, Barbara, et al.
Publicado: (2020)

Editorial: Redox metabolism: a double edge sword sustaining the adaptive resistance to therapy in cancer
por: Marengo, Barbara, et al.
Publicado: (2023)

Intra-source provenance study on Monte Arci (Sardinia) obsidian by pXRF: Role of the data acquisition and analysis tools
por: Mameli, Valentina, et al.
Publicado: (2023)

Dendrimer Nanodevices and Gallic Acid as Novel Strategies to Fight Chemoresistance in Neuroblastoma Cells
por: Alfei, Silvana, et al.
Publicado: (2020)

Iminosugar-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Potential Anti-Pancreatic Cancer Agents
por: Conforti, Irene, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ae4a0i5g2o1geog8037am6fksg